Biocept: Up on COVID-19 testing, progress with collection kits

Biocept

06/10/2020 14:07

** Shares of test maker  BIOC.O  rise 2.51% to $4.90
premarket
    ** Co says it has received more than 50,000 COVID-19
specimens to date for processing  urn:newsml:reuters.com:*:nPn4Bf1v0a       
    ** BIOC also reports progress with its internally developed
COVID-19 specimen collection kits, which it plans to send to
U.S. FDA for emergency use authorization review 
    ** Says on track to launch kits later this year for use in
its lab and for sales to other labs
    ** Up to last close, BIOC stock up ~67% YTD

 (Reporting by Vishwadha Chander in Bengaluru)
 ((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 6132;))